Fifth Third Bancorp Boosts Holdings in Solventum Corporation $SOLV

Fifth Third Bancorp boosted its holdings in shares of Solventum Corporation (NYSE:SOLV) by 1,749.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 67,856 shares of the company’s stock after buying an additional 64,187 shares during the quarter. Fifth Third Bancorp’s holdings in Solventum were worth $4,431,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Hilltop National Bank raised its position in Solventum by 71.3% in the fourth quarter. Hilltop National Bank now owns 310 shares of the company’s stock worth $25,000 after acquiring an additional 129 shares during the period. CrossGen Wealth LLC bought a new stake in shares of Solventum during the 4th quarter valued at $25,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Solventum in the 3rd quarter worth $25,000. JNBA Financial Advisors increased its stake in shares of Solventum by 205.4% in the 4th quarter. JNBA Financial Advisors now owns 339 shares of the company’s stock worth $27,000 after purchasing an additional 228 shares in the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new stake in shares of Solventum in the 2nd quarter worth $28,000.

Solventum Price Performance

SOLV opened at $81.36 on Friday. The business has a fifty day moving average of $77.09 and a 200 day moving average of $74.27. The company has a quick ratio of 0.75, a current ratio of 1.07 and a debt-to-equity ratio of 0.96. The stock has a market cap of $14.09 billion, a P/E ratio of 9.97, a PEG ratio of 1.25 and a beta of 0.66. Solventum Corporation has a 52-week low of $62.38 and a 52-week high of $88.20.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.35 by $0.13. The company had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Solventum had a net margin of 17.33% and a return on equity of 23.51%. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the business posted $1.34 EPS. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. As a group, sell-side analysts anticipate that Solventum Corporation will post 6.58 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. KeyCorp lifted their price objective on Solventum from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. BMO Capital Markets started coverage on shares of Solventum in a report on Wednesday, July 8th. They issued a “market perform” rating and a $81.00 price target on the stock. Wedbush began coverage on shares of Solventum in a report on Friday, May 15th. They set an “outperform” rating and a $94.00 price objective for the company. Stifel Nicolaus reduced their target price on Solventum from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Finally, Weiss Ratings raised Solventum from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday. Six analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Solventum presently has a consensus rating of “Hold” and an average price target of $81.91.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.